Atlas Trials

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

Clinical trial NCT06261918 · UNKNOWN

Trial details

NCT number
NCT06261918
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast CancerMetabolic Syndrome
Start date
2024-02-01
Primary completion
2025-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.